Grants for Small businesses - Health

This funding opportunity provides financial support to state and local governments, educational institutions, nonprofits, and other organizations to implement strategies that promote better nutrition and physical activity, ultimately reducing chronic disease risks in their communities.

This funding opportunity supports institutions in developing training programs for predoctoral and postdoctoral researchers focused on advancing knowledge and skills in aging research, aiming to prepare a diverse group of scientists for careers in this critical field.

The purpose of this funding opportunity is to develop artificial intelligence tools and experimental assays to identify new pharmacotherapeutics with lower toxicity and higher efficacy for substance use disorders (SUD) Areas of interest include but are not limited to: 1) Development of AI tools to identify potential target combinations, design new molecules, conduct virtual preclinical studies to predict efficacy and toxicity, and model in vitro and in vivo polypharmacology 2) Development of assays to assess the effects of compounds on multiple targets or functions

This funding opportunity supports innovative research and development in biological technologies that enhance national security, targeting universities, nonprofits, small businesses, and industry participants, particularly those with commercial potential.

Vernon County is offering grant funding through the National Opioid Settlement to support projects related to the abatement, prevention, treatment, and recovery of opioid drug use and its effects. The funding is available to non-profit organizations, businesses, schools, and local governmental agencies in Vernon County. Eligible projects should align with the values and mission of the Opioid Prevention and Abatement Steering Committee and focus on efforts to educate, train, reduce, and prevent harm from opioids. Applicants can request funding ranging from $100 to $25,000 per application, with a limit of one application per calendar year and a total of three applications per project. There will be three application periods offered each year. To apply, applicants will need to present their proposal to the Opioid Steering Committee, with presentations limited to 5 minutes followed by a question and answer session. It is important to note that projects unrelated to opioid prevention or mitigation efforts, requests for existing debt, expenses that have already been invoiced or paid, and any other expenses deemed ineligible by the Opioid Steering Committee will not be considered for funding.

The National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) with other NIH Institutes and Centers (ICs), intends to publish a new Notice of Funding Opportunity (NOFO) to solicit applications for multi-PI team-based, challenging, high impact projects to improve understanding of mechanisms of chronic pain in children and adolescents and to accelerate the development of age appropriate, patient/family centered prevention and therapeutic approaches. This research will seek to advance an integrated understanding of the biological, psychological, and social factors that contribute to pediatric chronic pain. NIH is interested in pain research in infants, children, and adolescents that includes those with intellectual and physical disabilities and/or those who experience health disparities (e.g., diverse race/ethnicity, sexual and gender minorities, socioeconomically disadvantaged, medically underserved communities, people with limited English proficiency). NIH encourages applicants to consider community-engaged research and interdisciplinary, collaborative applications to be developed in partnership with patient communities and/or community organizations where possible. The long-term goal is to develop improved knowledge of specific pediatric pain conditions as well as pain associated with diverse diseases/disorders, to improve understanding of pain in the context of child development and to facilitate the stratification of patients with specific pain conditions and co-morbidities to accelerate chronic pain prevention and therapeutic clinical trials. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in May 2024 with an expected application due date in Fall 2024. This NOFO will utilize the UC2 Research Project Cooperative Agreements activity code. Details of the planned NOFO are provided below.

This program provides essential financial support to small businesses in Pennsylvania that have been negatively affected by the COVID-19 pandemic, helping them access working capital to sustain their operations.

The "Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology" grant aims to fund well-established structural biology resources at synchrotron facilities, with the goal of maintaining or upgrading them to current best practices, promoting their availability to the biomedical research community, and providing user training and support.

This funding opportunity provides financial support to small businesses developing new medications for treating alcohol use disorder and related organ damage, with a focus on advancing these therapies toward FDA approval.

This funding opportunity supports collaborative research projects by multidisciplinary teams focused on addressing significant challenges related to substance use disorders and their health consequences.

This funding opportunity supports small businesses in the U.S. to develop innovative solutions for diagnosing and treating health issues related to non-disordered drug use, such as complications from opioid and stimulant use.

This grant provides funding to U.S.-based small businesses to develop innovative health-related technologies that require clinical trials, with a focus on projects that align with the missions of the NIH and CDC.

The Washington State Department of Commerce (Commerce) is offering grant funding through its Community Reinvestment Project (CRP) to support community healer services. This initiative aims to address violence and its systemic roots, particularly in Black, Latine, and tribal communities, which have been historically impacted by the "war on drugs" and systemic injustices. The program aligns with a mission to foster holistic, trauma-informed, person and community-centered, and culturally responsive services. It emphasizes flexibility and low-barrier innovation to serve those in need of restoration, accountability, and healing, thereby supporting personal and intergenerational healing, burnout prevention, and repairing harm caused by systemic racism, anti-Blackness, and colonialism. The primary beneficiaries of this grant are individuals and communities affected by violence, with a specific focus on Black, Latine, and tribal communities, including urban Indians. The impact goals are centered on violence intervention and prevention, promoting healing, and addressing the long-term consequences of historical injustices. By supporting community healer services, the program seeks to create safer, more resilient communities where individuals can experience restoration and healing from trauma. The program's priorities and focuses include addressing violence that has disproportionately affected Black, Latine, and tribal communities due to the design and enforcement of state and federal criminal laws for drug possession. It prioritizes organizations led by and for these communities, including federally recognized tribal governments, tribal-led 501(c)3s, tribal-led community-based organizations, small businesses, non-profits, faith-based organizations, and grassroots community-led organizations. Geographic priority counties are Clark, King, Pierce, Snohomish, Spokane, and Yakima in Washington State. Expected outcomes include providing culturally responsive services to people of all ages, identities, and abilities, fostering personal and intergenerational healing, and preventing burnout among community healers. Measurable results would likely focus on the reach and effectiveness of the violence intervention and prevention programs, the number of individuals served, and indicators of community restoration and healing. While specific metrics are not detailed in the provided information, the emphasis on accountability and healing suggests an outcomes-based approach. The foundation's strategic priorities and theory of change are rooted in the belief that addressing the historical and ongoing impacts of systemic racism, anti-Blackness, and colonialism through community-led healing initiatives is crucial for violence prevention and community reinvestment. By empowering by-and-for organizations within impacted communities, the program aims to facilitate sustainable change and create environments conducive to healing and well-being. The tiered funding structure, ranging from $50,000 to $500,000, reflects a commitment to supporting organizations of varying sizes, from small-sized with annual budgets under $150,000 to large-sized with budgets over $1 million, ensuring broad access to funding for eligible entities. The project period is set to begin around August 15, 2024, and conclude on June 30, 2025, allowing for a concentrated effort within a one-year grant duration. Eligibility criteria underscore the commitment to community-led initiatives, requiring organizations to be a federally recognized tribal government, tribal-led 501(c)3, tribal-led community-based organization, or licensed to do business in Washington (with an exception for tribes). Additionally, eligible organizations must be registered with the Community Reinvestment Project as a by-and-for organization, ensuring that the healing services are deeply connected to and guided by the communities they serve.

This funding opportunity supports research on non-invasive brain stimulation techniques to better understand and treat substance use disorders by exploring their effects on cognitive and neurobiological processes in humans.

This grant provides funding for collaborative, arts-based projects that improve community livability and cultural vibrancy in Pennsylvania, focusing on diversity, equity, and local engagement.

This funding opportunity provides financial support to organizations aiming to improve healthcare services and operational efficiency in rural healthcare facilities across the Delta region.

This funding opportunity supports researchers and organizations developing innovative prediction models for early detection of Alzheimer's Disease and related dementias, particularly focusing on data from underserved communities to address health disparities.

This funding opportunity supports research projects that utilize existing cancer epidemiology cohort data to investigate important questions about cancer prevention, treatment, and survivorship, particularly for underserved populations and rare cancers.

The National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for the TrialNet Coordinating Center (TNCC). The TrialNet network identifies people with type 1 diabetes (T1D) at stages before and after onset of clinical symptoms and enrolls them in trials and studies aimed at prevention of progression to clinical disease and preservation of insulin production. The TNCC participates in ongoing studies and intervention trials as well as the design and conduct of new studies and intervention trials. The TNCC will: (1) support a wide range of research projects in varying stages of development, implementation and completion, and (2) provide data and sample management, including standardized acquisition, quality control, dissemination and public accessibility. The TNCC will be responsible for network administration and operations, including the evaluation, selection, and funding (through subcontracts) of Clinical Centers and central support units (such as laboratories) necessary for the conduct of TrialNets clinical studies. The TNCC PD/PI will be a voting member of the TrialNet Executive and Steering Committees, contributing to network leadership. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. This NOFO will utilize the U01 activity code. Details of the planned NOFO are provided below.

This funding opportunity provides up to $1 million to a wide range of organizations to develop a centralized resource for exploring and analyzing single-cell genomics data from the human brain, enhancing research on brain health and disease.